Cover Image

Drug Delivery for the Retina and Posterior Segment Disease

This book addresses the issues relating to a wide variety of ocular diseases from which millions of people suffer. Long-term challenges include visual impairment and ocular blindness. Certain ocular diseases are quite rare, whereas others, such as cataracts, age-related macular degeneration (AMD), a...

Full description

Corporate Author: SpringerLink (Online service)
Other Authors: Patel, Jayvadan K. (Editor, http://id.loc.gov/vocabulary/relators/edt), Sutariya, Vijaykumar. (Editor, http://id.loc.gov/vocabulary/relators/edt), Kanwar, Jagat Rakesh. (Editor, http://id.loc.gov/vocabulary/relators/edt), Pathak, Yashwant V. (Editor, http://id.loc.gov/vocabulary/relators/edt)
Language:English
Published: Cham : Springer International Publishing : Imprint: Springer, 2018.
Edition:1st ed. 2018.
Subjects:
Pharmaceutical technology.
Ophthalmology.
Pharmaceutical Sciences/Technology.
Online Access:https://doi.org/10.1007/978-3-319-95807-1
Table of Contents:
  • Part I- Introduction and basic concept of drug delivery for retina and posterior segment disease
  • Anatomy and physiology of retina and posterior segment of the eye
  • Pharmacotherapy of diabetic macular edema and retinopathy
  • Drug delivery to posterior segment of eye: Conventional delivery strategies, their barriers and restrictions
  • Penetration routes to retina and posterior segment
  • Diabetic Retinopathy: Pathogenesis, Treatment, and Complications
  • PART II-Nanotechnology based formulations for retina and posterior segment disease
  • Liposomes for retina and posterior segment disease
  • Nano/microparticles for retina and posterior segment disease
  • Non-viral delivery systems for gene therapy for retina and posterior segment disease
  • Oxidative stress in ocular disorders: Exploring the link to pesticide exposure and potential for using nanotechnology for antioxidant delivery
  • Advances in the microbial infection in cornea and role of nanotechnology to cure ocular surface
  • Nanomedicine based delivery to the posterior segment of eye: Brighter tomorrow
  • Part III-Transscleral iontophoresis for retina and posterior segment disease
  • Transscleral drug delivery to retina and posterior segment disease
  • Colloidal carrier systems transscleral drug delivery
  • Transscleral Iontophoretic Drug Delivery for Treating Retinal Diseases
  • Part IV-Implant formulation for posterior eye segment
  • Biodegradable polymeric implants for retina and posterior segment disease
  • Nanomedicine based gene delivery for the retina and posterior segment diseases
  • Part V-Prodrug strategies for retina and posterior segment disease
  • Transporter targeted Pro-drug approach for retina and posterior segment disease
  • Lipid Prodrug based delivery for retina and posterior segment disease
  • Injectable Pro-drugs approach for retina and posterior segment disease
  • Stereoisomeric dipeptide Pro-drug approach for retina and posterior segment disease
  • Part VI-Other advances for retina and posterior segment diseases
  • Receptor targeted Pro-drug approach for retina and posterior segment disease
  • Intravitreal injection drug delivery for retina and posterior segment disease: Challenges and Future ahead
  • Thermoresponsive gels drug delivery for retina and posterior segment disease
  • Peptide synthesis and delivery for retina and posterior segment disease
  • Corneal haze, refractive surgery and its implications on choroidal neovascularisation. .

Similar Items